


The Diagnostic Panel for Metabolic Diseases and Mitochondriopathies has been updated and expanded
To increase clinical usability, the composition of the gene…


Study: Prenatal Trio Exome Sequencing Clarifies Ultrasound Abnormalities with a Solution Rate of 38%
Prenatal trio exome analysis is a highly sensitive method for…

Update and Extension of the Panel for Epilepsy and Brain Development Disorders
According to the latest clinical findings, we updated and expanded…



Identification of HLA I and II Alleles Using Next-Generation Sequencing
CeGaT has updated and expanded its HLA typing portfolio. In…

New Tech Note Released: Discover the Different Options of RNA Sequencing Designed for your Needs
Transcriptome sequencing is a very sensitive method to analyze…
Genetic Diagnostics
Research & Pharma Solutions

CeGaT is a provider of genetic diagnostics and NGS services. The company is based in Tübingen, Germany and is accredited according to CAP, CLIA, DIN EN ISO 15189 and DIN EN ISO 17025.